Maria Laura Bolognesi

Maria Laura Bolognesi

Università degli Studi di Bologna

H-index: 57

Europe-Italy

About Maria Laura Bolognesi

Maria Laura Bolognesi, With an exceptional h-index of 57 and a recent h-index of 37 (since 2020), a distinguished researcher at Università degli Studi di Bologna, specializes in the field of Drug discovery, chemical biology, neurodegenerative diseases, neglected tropical diseases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Empowering Voices: Inspiring Women in Medicinal Chemistry

Targeting Lewy body dementia with neflamapimod‐rasagiline hybrids

Triazinones as the first dual BACE-1/GSK-3β fragment hits against Alzheimer’s disease

Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis

Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies

Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease

Valorizing Constituents of Cashew Nut Shell Liquid toward the Sustainable Development of New Drugs against Chagas Disease

PROTAC-induced glycogen synthase kinase 3β degradation as a potential therapeutic strategy for Alzheimer’s Disease

Maria Laura Bolognesi Information

University

Position

___

Citations(all)

11756

Citations(since 2020)

5217

Cited By

8766

hIndex(all)

57

hIndex(since 2020)

37

i10Index(all)

153

i10Index(since 2020)

105

Email

University Profile Page

Università degli Studi di Bologna

Google Scholar

View Google Scholar Profile

Maria Laura Bolognesi Skills & Research Interests

Drug discovery

chemical biology

neurodegenerative diseases

neglected tropical diseases

Top articles of Maria Laura Bolognesi

Title

Journal

Author(s)

Publication Date

Empowering Voices: Inspiring Women in Medicinal Chemistry

Maria-Jesus Blanco

Joanne J Bronson

Erin F DiMauro

Carolyn Dzierba

MariJean Eggen

...

2024/3/8

Targeting Lewy body dementia with neflamapimod‐rasagiline hybrids

Archiv der Pharmazie

Claudia Albertini

Sabrina Petralla

Francesca Massenzio

Barbara Monti

Nicola Rizzardi

...

2024/2/27

Triazinones as the first dual BACE-1/GSK-3β fragment hits against Alzheimer’s disease

Federica Prati

Angela De Simone

Andrea Armirotti

Maria Summa

Daniela Pizzirani

...

2024/2/19

Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis

Journal of Medicinal Chemistry

Cécile Exertier

Alessandra Salerno

Lorenzo Antonelli

Annarita Fiorillo

Riccardo Ocello

...

2024/1/2

Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies

Archiv der Pharmazie

Gülşah Bayraktar

Manuela Bartolini

Maria Laura Bolognesi

Mumin Alper Erdoğan

Güliz Armağan

...

2024/4/9

Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease

Bioorganic & Medicinal Chemistry

Elisa Uliassi

Christian Bergamini

Nicola Rizzardi

Marina Naldi

Ángel Cores

...

2023/8/15

Valorizing Constituents of Cashew Nut Shell Liquid toward the Sustainable Development of New Drugs against Chagas Disease

ACS Infectious Diseases

Laís Flávia Nunes Lemes

George E Magoulas

Andressa Souza de Oliveira

Emile Barrias

Luciana de Camargo Nascente

...

2023/6/12

PROTAC-induced glycogen synthase kinase 3β degradation as a potential therapeutic strategy for Alzheimer’s Disease

ACS Chemical Neuroscience

Melissa Guardigni

Letizia Pruccoli

Alan Santini

Angela De Simone

Matteo Bersani

...

2023/5/23

Therapeutic strategies for identifying small molecules against prion diseases

Elisa Uliassi

Lea Nikolic

Maria Laura Bolognesi

Giuseppe Legname

2023/4

Bifunctional carbazole derivatives for simultaneous therapy and fluorescence imaging in prion disease murine cell models

European Journal of Medicinal Chemistry

Matteo Staderini

Silvia Vanni

Arianna Colini Baldeschi

Gabriele Giachin

Marco Zattoni

...

2023/1/5

Phenothiazine‐based virtual screening, molecular docking, and molecular dynamics of new trypanothione reductase inhibitors of Trypanosoma cruzi

Molecular Informatics

Alonzo González‐González

Citlali Vázquez

Rusely Encalada

Emma Saavedra

Lenci K Vázquez‐Jiménez

...

2023/10

Targeted Protein Degradation for Infectious Diseases: From Basic Biology to Drug Discovery

Rocío Marisol Espinoza-Chávez

Alessandra Salerno

Anastasia Liuzzi

Andrea Ilari

Andrea Milelli

...

2022/12/15

Enriching proteolysis targeting chimeras with a second modality: When two are better than one

Alessandra Salerno

Francesca Seghetti

Jessica Caciolla

Elisa Uliassi

Eleonora Testi

...

2022/7/11

Innovative non-PrP-targeted drug strategy designed to enhance prion clearance

Journal of medicinal chemistry

Arianna Colini Baldeschi

Marco Zattoni

Silvia Vanni

Lea Nikolic

Chiara Ferracin

...

2022/6/30

The use of Zidovudine pharmacophore in multi-target-directed ligands for AIDS therapy

Maria da Conceição Avelino Dias Bianco

Debora Inacio Leite

Frederico Silva Castelo Branco

Nubia Boechat

Elisa Uliassi

...

2022/12/3

Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library

Pharmaceutics

Angela Lauriola

Elisa Uliassi

Matteo Santucci

Maria Laura Bolognesi

Marco Mor

...

2022/2/10

Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease

ACS chemical neuroscience

Annachiara Gandini

Ana Elisa Gonçalves

Silvia Strocchi

Claudia Albertini

Jana Janočková

...

2022/11/29

In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione …

International Journal of Molecular Sciences

Alonzo González-González

Oscar Sánchez-Sánchez

R Luise Krauth-Siegel

Maria Laura Bolognesi

Rogelio Gớmez-Escobedo

...

2022/11/1

PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION

A Santini

L Pruccoli

M Guardigni

A De Simone

F Spyrakis

...

2022

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis

ACS Chemical Neuroscience

Claudia Albertini

Alessandra Salerno

Silvia Atzeni

Elisa Uliassi

Francesca Massenzio

...

2022/7/22

See List of Professors in Maria Laura Bolognesi University(Università degli Studi di Bologna)